Jointly with Jikei University, Mani Inc., Asahi Kasei and the Japan Medical Devices Development Organization (JOMDD), a stent graft with a smaller diameter and less invasive treatment will be developed. Regulatory approval will be sought at the same time in Japan, the United States and Europe, and preclinical studies should be completed in 2020.

Kawasumi Chemicals news release, February 8, 2018